BUSINESS3 years ago
Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma Announce Approval of KORSUVATM
Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma have announced that the U.S Food and Drug Administration (FDA) has approved KORSUVA™ (difelikefalin) to treat moderate to...